Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Cited by (1,004)

Items 101–200 of 1,004

1. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
   Lamiaa El-Shennawy, Andrew Daniel Hoffmann, Nurmaa Khund Dashzeveg, Kathleen M. McAndrews, Paul J. Mehl, Daphne Cornish, Zihao Yu, Valerie L. Tokars, Vlad I. Nicolaescu, Αναστασία Τοματσίδου et al. · 2022 · Nature Communications
2. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
   Alejandro Jara, Eduardo A. Undurraga, José R Zubizarreta, Cecilia González, Alejandra Pizarro, Johanna Acevedo, Katherinne Leo, Fabio Paredes, Tomás Bralic, Verónica Vergara et al. · 2022 · The Lancet Global Health
3. The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
   Gary R. McLean, Jeremy P. Kamil, Benhur Lee, Penny L. Moore, Thomas Friedrich Schulz, Alexander Muik, Uğur Şahin, Özlem Türeci, Shanti Pather · 2022 · mBio
4. Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant
   Paul Elliott, David Haw, Haowei Wang, Oliver D. Eales, Caroline E. Walters, Kylie E. C. Ainslie, Christina Joanne Atchison, Claudio Fronterrè, Peter John Diggle, Andrew J. Page et al. · 2021 · Science
5. Confronting the Delta Variant of SARS-CoV-2, Summer 2021
   Carlos del Rı́o, Preeti Malani, Saad B. Omer · 2021 · JAMA
6. Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
   Timothy Farinholt, HarshaVardhan Doddapaneni, Xiang Qin, Vipin K. Menon, Qingchang Meng, Ginger Metcalf, Hsu Chao, Marie‐Claude Gingras, Vasanthi Avadhanula, Paige Farinholt et al. · 2021 · BMC Medicine
7. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
   Renuka Raman, Krishna J. Patel, Kishu Ranjan · 2021 · Biomolecules
8. Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
   Christopher Davis, Nicola A. Logan, Grace B. Tyson, Richard J Orton, William T. Harvey, Jonathan S. Perkins, Guy Mollett, Rachel Blacow, Thomas P. Peacock, William Barclay et al. · 2021 · PLoS Pathogens
9. Public health impact of covid-19 vaccines in the US: observational study
   Amitabh Bipin Suthar, Jing Wang, Victoria Seffren, Ryan E. Wiegand, Sean Griffing, Elizabeth Zell · 2022 · BMJ
10. Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy
    Azizul Haque, Anudeep B. Pant · 2022 · Journal of Autoimmunity
11. Microfluidics for nano-drug delivery systems: From fundamentals to industrialization
    Huan Zhang, Jie Yang, Rongze Sun, Songren Han, Zhaogang Yang, Le-Sheng Teng · 2023 · Acta Pharmaceutica Sinica B
12. COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
    Kirsebom, Freja C M, Andrews, Nick, Stowe, Julia, Toffa, Samuel, Sachdeva, Ruchira, Gallagher, Eileen, Groves, Natalie, O'Connell, Anne-Marie, Chand, Meera, Ramsay, Mary et al. · 2022 · The Lancet Infectious Diseases
13. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
    Annika Fendler, Scott T.C. Shepherd, Lewis Au, Katalin Andrea Wilkinson, Mary Wu, Fiona Byrne, Maddalena Cerrone, Andreas Michael Schmitt, Nalinie Joharatnam‐Hogan, Benjamin Shum et al. · 2021 · Nature Cancer
14. Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
    Alexandra Suberi, Molly K. Grun, Tianyang Mao, Benjamin Israelow, Melanie Reschke, Julian Grundler, Laiba Akhtar, Teresa Lee, Kwangsoo Shin, Alexandra S. Piotrowski-Daspit et al. · 2023 · Science Translational Medicine
15. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
    Fanglei Zuo, Hassan Abolhassani, Likun Du, Antonio Piralla, Federico Bertoglio, Leire de Campos‐Mata, Hui Wan, Maren Schubert, Irene Cassaniti, Yating Wang et al. · 2022 · Nature Communications
16. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study
    Gazit, Sivan, Shlezinger, Roei, Perez, Galit, Lotan, Roni, Peretz, Asaf, Ben-Tov, Amir, Herzel, Esma, Alapi, Hillel, Cohen, Dani, Muhsen, Khitam et al. · 2022 · Clinical Infectious Diseases
17. Population antibody responses following COVID-19 vaccination in 212,102 individuals
    Helen Ward, Matthew D. Whitaker, Barnaby Flower, Sonja N. Tang, Christina Joanne Atchison, Ara Wardkes Darzi, Christl Ann Donnelly, Alexandra Cann, Peter John Diggle, Deborah Ashby et al. · 2022 · Nature Communications
18. COVID-19 in long-term care
    Eileen Rocard, Paola Sillitti, Ana Llena Nozal · 2021 · OECD health working papers
19. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
    Raphael Sonabend, Lilith K Whittles, Natsuko Imai, Pablo N Perez-Guzman, Edward S Knock, Thomas Rawson, Katy A. M. Gaythorpe, Bimandra A Djaafara, Wes R. Hinsley, Richard G. FitzJohn et al. · 2021 · The Lancet
20. Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study
    Stowe, Julia, Andrews, Nick, Kirsebom, Freja, Ramsay, Mary, Bernal, Jamie Lopez · 2022 · Nature Communications
21. Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
    Heather Whitaker, Ruby S. M. Tsang, Rachel C. Byford, Nick J Andrews, Julian Sherlock, Praveen Sebastian Pillai, John Williams, Elizabeth Button, Helen Campbell, Mary Sinnathamby et al. · 2022 · Journal of Infection
22. Nature’s contributions in coping with a pandemic in the 21st century: A narrative review of evidence during COVID-19
    S.M. Labib, Matthew H. E. M. Browning, Alessandro Rigolon, Marco Helbich, Peter James · 2021 · EcoEvoRxiv
23. Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
    Piotr Rzymski, Barbara Poniedziałek, Andrzej Fal · 2021 · Vaccines
24. SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
    Suresh Thakur, Shalitha Sasi, Sindhu Gopinathan Pillai, Ayantika Nag, Dhananjay Shukla, Ritu Singhal, Sameer Phalke, G. S. K. Velu · 2022 · Frontiers in Medicine
25. Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
    Jocelyn Keehner, Lucy E. Horton, NANCY J. BINKIN, Louise Chang Laurent, David T. Pride, Chris Longhurst, Shira R. Abeles, Francesca J. Torriani · 2021 · New England Journal of Medicine
26. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
    Katherine D. Linsenmeyer, Kalpana Gupta, Michael E. Charness · 2021 · New England Journal of Medicine
27. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
    Monika Kumari, Ruei‐Min Lu, Mu‐Chun Li, Jhih‐Liang Huang, Fu‐Fei Hsu, Shih-Han Ko, Feng-Yi Ke, Shih-Chieh Su, Kang-Hao Liang, Joyce Pei‐Yi Yuan et al. · 2022 · Journal of Biomedical Science
28. Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
    Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, Logan T. Neel, Tharanath Shankar, Shriya Patel, Payton Lowery, Forrest Smith, Muralikrishnan Dhanasekaran, Timothy Moore · 2021 · Vaccines
29. Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years — United States, August 2020–August 2021
    Siegel, David A., Reses, Hannah E., Cool, Andrea J., Shapiro, Craig N., Hsu, Joy, Boehmer, Tegan K., Cornwell, Cheryl R., Gray, Elizabeth B., Henley, S. Jane, Lochner, Kimberly et al. · 2021 · MMWR. Morbidity and Mortality Weekly Report
30. Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France
    Rebecca Grant, Tiffany Charmet, Laura Schaeffer, Simon Galmiche, Yoann Madec, Cassandre Von Platen, Olivia Chény, Faïza Omar, Christophe David, Alexandra Rogoff et al. · 2021 · The Lancet Regional Health - Europe
31. Antibody-mediated neutralization of SARS-CoV-2
    Henning Gruell, Kanika Vanshylla, Timm Weber, Christopher O. Barnes, Christoph Kreer, Florian Klein · 2022 · Immunity
32. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study
    Gram, Mie Agermose, Emborg, Hanne-Dorthe, Schelde, Astrid Blicher, Friis, Nikolaj Ulrik, Nielsen, Katrine Finderup, Moustsen-Helms, Ida Rask, Legarth, Rebecca, Lam, Janni Uyen Hoa, Chaine, Manon, Malik, Aisha Zahoor et al. · 2022 · PLOS Medicine
33. Effectiveness of heterologous and homologous COVID-19 vaccine regimens: living systematic review with network meta-analysis
    Au, Wing Ying, Cheung, Peter Pak-Hang · 2022 · BMJ
34. Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
    Takuya Tada, Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Vidya Chivukula, Ramin S. Herati, Stevan R. Hubbard, Mark J. Mulligan, Nathaniel Roy Landau · 2022 · EBioMedicine
35. Evolutionary trajectory of SARS-CoV-2 and emerging variants
    Jalen Singh, Pranav Pandit, Andrew G. McArthur, Arinjay Banerjee, Karen Louise Mossman · 2021 · Virology Journal
36. Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity
    Tsai, Shang Jui, Atai, Nadia A., Cacciottolo, Mafalda, Nice, Justin, Salehi, Arjang, Guo, Chenxu, Sedgwick, Alanna, Kanagavelu, Saravana, Gould, Stephen J. · 2021 · Journal of Biological Chemistry
37. Rapid increase in Omicron infections in England during December 2021: REACT-1 study
    Paul Elliott, Barbara Bodinier, Oliver D. Eales, Haowei Wang, David Haw, Joshua Elliott, Matthew D. Whitaker, Jakob Jonnerby, David G. Tang, Caroline E. Walters et al. · 2022 · Science
38. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination
    Wan Yang, Jeffrey L. Shaman · 2022 · Journal of The Royal Society Interface
39. Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
    Cong Sun, Chu Xie, Guo‐Long Bu, Lan‐Yi Zhong, Mu‐Sheng Zeng · 2022 · Signal Transduction and Targeted Therapy
40. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication
    Junjun Chu, Changsheng Xing, Yang Du, Tianhao Duan, Siyao Liu, Pengfei Zhang, Chumeng Cheng, Jill E. Henley, Xin Liu, Qian Chen et al. · 2021 · Nature Metabolism
41. Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
    Skowronski, Danuta M, Febriani, Yossi, Ouakki, Manale, Setayeshgar, Solmaz, El Adam, Shiraz, Zou, Macy, Talbot, Denis, Prystajecky, Natalie, Tyson, John R, Gilca, Rodica et al. · 2022 · Clinical Infectious Diseases
42. Two Years into the COVID-19 Pandemic: Lessons Learned
    Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, Klarissa Miranda Guarines, Caroline Targino Alves da Silva, Poliana Gomes da Silva, Jurandy Júnior Ferraz de Magalhães, Justin R. J. Vigar, Abelardo Silva‐Júnior, Alain Kohl et al. · 2022 · ACS Infectious Diseases
43. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021
    Thomas Harder, Wiebe Külper‐Schiek, Sarah Alicia Reda, Marina Treskova, Judith Koch, Sabine Vygen-Bonnet, Ole Wichmann · 2021 · Eurosurveillance
44. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil
    Katikireddi, Srinivasa Vittal, Cerqueira-Silva, Thiago, Vasileiou, Eleftheria, Robertson, Chris, Amele, Sarah, Pan, Jiafeng, Taylor, Bob, Boaventura, Viviane, Werneck, Guilherme Loureiro, Flores-Ortiz, Renzo et al. · 2022 · The Lancet
45. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion
    Frederic Grabowski, Marek Kochańczyk, Tomasz Lipniacki · 2022 · Viruses
46. A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
    Melissa M. Higdon, Brian Wahl, Carli B. Jones, Joseph G. Rosen, Shaun Truelove, Anurima Baidya, Anjalika Nande, Parisa A ShamaeiZadeh, Karoline K Walter, Daniel R. Feikin et al. · 2022 · Open Forum Infectious Diseases
47. Effectiveness of message framing in changing COVID-19 vaccination intentions: Moderating role of travel desire
    Doğan Gürsoy, Yüksel Ekinci, Ali Selçuk Can, Jessica C. Murray · 2021 · Tourism Management
48. Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis
    Célestin Danwang, Jean Jacques Noubiap, Annie R Robert, Jean Cyr Yombi · 2022 · AIDS Research and Therapy
49. SARS‐CoV‐2 variants and vulnerability at the global level
    Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya · 2022 · Journal of Medical Virology
50. A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2
    Junyu Chen, Pui Wang, Lunzhi Yuan, Liang Zhang, Limin Zhang, Hui John Zhao, Congjie Chen, Yaode Chen, Jinle Han, Jizong Jia et al. · 2022 · 中国科学通报：英文版
51. RETRACTED: Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
    Manish K. Dhawan, AbdulRahman A. Saied, Saikat Mitra, Fahad Abdulrahman Alhumaydhi, Talha Bin Emran, Polrat Wilairatana · 2022 · Biomedicine & Pharmacotherapy · Retracted
52. Vaccinations Against COVID-19 May Have Averted Up To 140,000 Deaths In The United States
    Sumedha Gupta, Jonathan Cantor, Kosali Ilayperuma Simon, Ana I. Bento, Coady Wing, Christopher Whaley · 2021 · Health Affairs
53. Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
    Gregory Milne, Thomas Hames, Chris J. Scotton, Nick Gent, Alexander Johnsen, Roy Malcolm Anderson, Tom Ward · 2021 · The Lancet Respiratory Medicine
54. Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
    Paul A. Christensen, Randall J. Olsen, Scott Wesley Long, Sishir Subedi, James J. Davis, Parsa Hodjat, Debbie R. Walley, Jacob C. Kinskey, Matthew Ojeda Saavedra, Layne Pruitt et al. · 2021 · American Journal Of Pathology
55. Context-specific emergence and growth of the SARS-CoV-2 Delta variant
    John T. McCrone, Verity Hill, Sumali Bajaj, Rosario Evans Pena, Ben C. Lambert, Rhys P. D. Inward, Samir Bhatt, Erik Volz, Christopher Ruis, Simon Dellicour et al. · 2022 · Nature
56. Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors
    Doll, Margaret K, Pettigrew, Stacy M, Ma, Julia, Verma, Aman · 2022 · Clinical Infectious Diseases
57. Increased risk for COVID ‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
    Lindsey Wang, QuanQiu Wang, Pamela B. Davis, Nora D. Volkow, Rong Xu · 2021 · World Psychiatry
58. Multilevel determinants of COVID-19 vaccination hesitancy in the United States: A rapid systematic review
    Ying Wang, Yu Liu · 2021 · Preventive Medicine Reports
59. Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)
    2022
60. Circular RNA: A promising new star of vaccine
    Jindong Xie, Fengxi Ye, Xinpei Deng, Yuhui Tang, Jie‐Ying Liang, Xufeng Huang, Yuying Sun, Hailin Tang, Jinsong Lei, Shaoquan Zheng et al. · 2023 · Journal of Translational Internal Medicine
61. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021
    Griffin, Jennifer B., Haddix, Meredith, Danza, Phoebe, Fisher, Rebecca, Koo, Tae Hee, Traub, Elizabeth, Gounder, Prabhu, Jarashow, Claire, Balter, Sharon · 2021 · MMWR. Morbidity and Mortality Weekly Report
62. Vaccine nationalism and the dynamics and control of SARS-CoV-2
    Caroline E. Wagner, Chadi M. Saad-Roy, Sinead E. Morris, Rachel E. Baker, Michael Joseph Mina, Jeremy Farrar, Edward Charles Holmes, Oliver G. Pybus, Andrea L. Graham, Ezekiel Emanuel et al. · 2021 · Science
63. Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School — Marin County, California, May–June 2021
    Lam-Hine, Tracy, McCurdy, Stephen A., Santora, Lisa, Duncan, Lael, Corbett-Detig, Russell, Kapusinszky, Beatrix, Willis, Matthew · 2021 · MMWR. Morbidity and Mortality Weekly Report
64. COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
    Müge Çevik, Nathan D. Grubaugh, Akiko Iwasaki, Peter Openshaw · 2021 · Cell
65. SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
    Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, Pourya Gholizadeh, Mohammad Asgharzadeh, Khudaverdi Ganbarov, Şükran Köse, Mehdi Yousefi, Hossein Samadi Kafil · 2021 · International Journal of Biological Macromolecules
66. Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
    Hajnik, Renee L., Plante, Jessica A., Liang, Yuejin, Alameh, Mohamad-Gabriel, Tang, Jinyi, Bonam, Srinivasa Reddy, Zhong, Chaojie, Adam, Awadalkareem, Scharton, Dionna, Rafael, Grace H. et al. · 2022 · Science Translational Medicine
67. mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
    Paulina Kapłonek, Stephanie Fischinger, Deniz Cizmeci, Yannic C. Bartsch, Jaewon Kang, John S. Burke, Sally A. Shin, Diana Dayal, Patrick Martin, Colin J. Mann et al. · 2022 · Immunity
68. Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
    Qiaoli Peng, Runhong Zhou, Yuewen Wang, Meiqing Zhao, Na Liu, Shuang Li, Haode Huang, Dawei Yang, Ka‐Kit Au, Hui Wang et al. · 2022 · EBioMedicine
69. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
    Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker, Anouschka Akerman, Camille Esneau, Vanessa Milogiannakis, Deborah Lilly Burnett, Samantha McAllery, Mariana Ruiz Silva, Yonghui Lu et al. · 2022 · Nature Microbiology
70. COVID ‐19 infection and the broader impacts of the pandemic on healthcare workers
    Natasha Smallwood, Warren Harrex, Megan Rees, Karen Willis, Catherine M. Bennett · 2022 · Respirology
71. Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir
    Kai S. Yang, Sunshine Z. Leeuwon, Shiqing Xu, Wenshe Ray Liu · 2022 · Journal of Medicinal Chemistry
72. Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models
    Han-Yi Huang, Hsin-Yu Liao, Xiaorui Chen, Szu-Wen Wang, Cheng-Wei Cheng, Md. Shahed-Al-Mahmud, Yo-Min Liu, Arpita Mohapatra, Ting-Hua Chen, Jennifer M. Lo et al. · 2022 · Science Translational Medicine
73. SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
    Danyi Ao, Tianxia Lan, Xuemei He, Jian Liu, Li Chen, Daniel Tomas Baptista‐Hon, Kang Zhang, Xiawei Wei · 2022 · MedComm
74. To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination
    Nan‐Chang Chiu, Hsin Chi, Yu‐Kang Tu, Ya-Ning Huang, Yu‐Lin Tai, Shun-Long Weng, Lung Chang, Daniel Tsung‐Ning Huang, Fu-Yuan Huang, Chien‐Yu Lin · 2021 · Expert Review of Vaccines
75. Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
    2021
76. Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy
    Lissenya B. Argueta, Lauretta A. Lacko, Yaron Bram, Takuya Tada, Lucía Carrau, André F. Rendeiro, Tuo Zhang, Skyler A. Uhl, Brienne Lubor, Vasuretha Chandar et al. · 2022 · iScience
77. Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years
    Winokur, Patricia, Gayed, Juleen, Fitz-Patrick, David, Thomas, Stephen J., Diya, Oyeniyi, Lockhart, Stephen, Xu, Xia, Zhang, Ying, Bangad, Vishva, Schwartz, Howard I. et al. · 2023 · New England Journal of Medicine
78. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
    Emma CB Wall, Mary Wu, Ruth Harvey, Gavin P. Kelly, Scott Warchal, Chelsea Sawyer, Rodney Stuart Daniels, Lorin Adams, Philip S. Hobson, Emine Hatipoglu et al. · 2021 · The Lancet
79. Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis
    Chen, Xinhua, Chen, Zhiyuan, Azman, Andrew S, Sun, Ruijia, Lu, Wanying, Zheng, Nan, Zhou, Jiaxin, Wu, Qianhui, Deng, Xiaowei, Zhao, Zeyao et al. · 2022 · Clinical Infectious Diseases
80. Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
    Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Shitu Mekonnen, Abtie Abebaw, Melese Getachew, Tengchuan Jin · 2021 · Seminars in Immunology
81. Droplet digital RT-PCR to detect SARS-CoV-2 signature mutations of variants of concern in wastewater
    Leo Heijnen, Goffe Elsinga, Miranda de Graaf, Richard Molenkamp, Marion Koopmans, Gertjan J. Medema · 2021 · The Science of The Total Environment
82. DNA vaccines for SARS-CoV-2: toward third-generation vaccination era
    Vivek P. Chavda, Radhika Pandya, Vasso Apostolopoulos · 2021 · Expert Review of Vaccines
83. A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
    Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, Asma Talukder · 2022 · VirusDisease
84. COVID-19 reinfections among naturally infected and vaccinated individuals
    Sezanur Rahman, Md Mahfuzur Rahman, Mojnu Miah, Mst. Noorjahan Begum, Monira Sarmin, Mustafa Mahfuz, Mohammad Enayet Hossain, Mohammed Ziaur Rahman, Mohammod Jobayer Chisti, Tahmeed Ahmed et al. · 2022 · Scientific Reports
85. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study
    Massimo Fabiani, Maria Puopolo, Cristina Morciano, Matteo Spuri, Stefania Spila Alegiani, Antonietta Filia, Fortunato “Paolo” D’Ancona, Martina Del Manso, Flavia Riccardo, Marco Tallon et al. · 2022 · BMJ
86. Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection
    Yang Yang, Minghui Yang, Yun Peng, Yanhua Liang, Jinli Wei, Li Xing, Liping Guo, Xiaohe Li, Jie Li, Jun Wang et al. · 2022 · Nature Microbiology
87. A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
    Zezhong Liu, Jie Zhou, Wei Xu, Wei Deng, Yanqun Wang, Meiyu Wang, Qian Wang, Ming Kun Hsieh, Jingming Dong, Xinling Wang et al. · 2022 · Cell Research
88. The Emergence of Omicron: Challenging Times Are Here Again!
    Tanu Singhal · 2022 · The Indian Journal of Pediatrics
89. Genomic reconstruction of the SARS-CoV-2 epidemic in England
    Harald S. Vöhringer, Theo Sanderson, Matthew Sinnott, Nicola De Maio, Thuy Nguyen, Richard Goater, Frank Schwach, Ian Harrison, Joel Hellewell, Cristina V. Ariani et al. · 2021 · Nature
90. COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study
    Miloslav Klugar, Abanoub Riad, Lekshmi Mohanan, Andrea Pokorná · 2021 · Vaccines
91. Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
    Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, Brent Appelman, Ilja Bontjer, Meliawati Poniman, Judith A. Burger, Melissa Oomen, Joey H. Bouhuijs, Lonneke A. van Vught et al. · 2022 · PLoS Medicine
92. An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
    Varghese Edwin Hillary, Stanislaus Antony Ceasar · 2023 · Heliyon
93. Effectiveness of a Third Dose of BNT162b2 mRNA COVID-19 Vaccine in a Large US Health System: A Retrospective Cohort Study
    Sara Yee Tartof, Jeff M. Slezak, Laura Puzniak, Vennis X. Hong, Timothy B. Frankland, Bradley K. Ackerson, Harpreet S. Takhar, Oluwaseye Ayoola Ogun, Sarah R. Simmons, Joann M. Zamparo et al. · 2021 · The Lancet Regional Health - Americas
94. Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories
    Yong Ge, Wenbin Zhang, Xilin Wu, Corrine Warren Ruktanonchai, Haiyan Liu, Jianghao Wang, Yongze Song, Mengxiao Liu, Wei Yan, Juan Yang et al. · 2022 · Nature Communications
95. Immune Memory Response After a Booster Injection of mRNA-1273 for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
    Chu, Laurence, Montefiori, David, Huang, Wenmei, Nestorova, Biliana, Chang, Ying, Carfi, Andrea, Edwards, Darin K., Oestreicher, Judy, Legault, Holly, Girard, Bethany et al. · 2021
96. Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
    Damariz Marín-Palma, Jorge Humberto Tabares-Guevara, Maria Isabel Zapata-Cardona, Lizdany Flórez‐Álvarez, Lina Marcela Restrepo Yepes, Marı́a Teresa Rugeles, Wildeman Zapata, Juan Carlos Hernández, Natalia A. Taborda · 2021 · Molecules
97. Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
    Lulu C Bravo, Igor V. Smolenov, Htay Htay Han, Ping Li, Romana Hosain, Frank W. Rockhold, Sue Ann Costa Clemens, Camilo C. Roa, Charissa Borja-Tabora, Antoinette Quinsaat et al. · 2022 · The Lancet
98. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
    Bao Vuong Duong, Puchanee Larpruenrudee, Tianxin Fang, Sheikh Imamul Hossain, Suvash C. Saha, Yuantong Gu, Mohammad S. Islam · 2022 · International Journal of Environmental Research and Public Health
99. From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World
    Mickensone Andre, Lee Seng Lau, Marissa D. Pokharel, Julian Ramelow, Florida Owens, Joseph Souchak, Juliet Akkaoui, Evan Ales, Harry H Brown, Rajib Kumar Shil et al. · 2023 · Biology
100. Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
     Liane Dupont, Luke B. Snell, Carl Graham, Jeffrey Seow, Blair Merrick, Thomas Lechmere, Thomas J. A. Maguire, Sadie R. Hallett, Suzanne Pickering, Themoula Charalampous et al. · 2021 · Nature Microbiology